Yale Cancer Center and Smilow Cancer Hospital physicians recognized as Connecticut Magazine 'Best Doctors'
Connecticut Magazine has named 90 Yale Cancer Center and Smilow Cancer Hospital physicians to its 2021 Best Doctors guide. Published in the magazine’s June issue, the 'Best Doctors' list consists of more than 1,500 Connecticut physicians from nearly 40 medical specialties.
- May 28, 2021
Two recent papers by Dr. Jen Moliterno and her team help physicians better identify patients who may develop seizures alongside meningiomas.
- May 21, 2021
The Blavatnik Fund for Innovation at Yale, made possible by a generous grant from the Blavatnik Family Foundation, supports Yale faculty in the commercialization of applied research and technology in the life sciences.
- May 11, 2021Source: YaleNews
A team of Yale School of Medicine researchers is launching a study to determine the effect of vaccination on people with persistent symptoms months after SARS-CoV-2 infection, which has been termed “Long COVID.”
- April 27, 2021
COVID-19: What We Know, What We Don’t Know & What is On The Horizon
- April 19, 2021
Yale Cancer Center Researchers Identify New Role for Immune-Boosting Protein “STING” in Treatment of Head and Neck Cancer
In a study by Yale Cancer Center, researchers report on the discovery of a new role for STimulator of INterferon Genes or STING. STING has traditionally been implicated in the immune response to DNA damage, however, in this study, the focus is on STING’s role in the tumor DNA damage response.
- April 12, 2021
Marina Picciotto, PhD, Charles B. G. Murphy Professor of Psychiatry and Professor in the Child Study Center, of Neuroscience and of Pharmacology, has been elected to the American College of Neuropsychopharmacology (ACNP) Council.
- April 09, 2021
The Association of American Physicians and the American Society for Clinical Investigation have each elected three new members from the Yale School of Medicine faculty.
- March 15, 2021
New Multidisciplinary Center for Lung Disease To Open in North Haven
- February 25, 2021Source: YaleNews
Yale scientists have developed a new class of antiviral agents that shows promise for creating COVID-19 therapeutics — exhibiting particular effectiveness when used in tandem with the drug remdesivir, another antiviral medication approved for use against the virus.